• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

A Study of Convulsive Status Epilepticus Cases in Indonesia
Publication date: Available online 14 March 2019Source: Epilepsy & Behavior Case ReportsAuthor(s): Machlusil Husna, K. Shahdevi Nandar, Risma Karlina Prabawati, Siti NurlaelaAbstractStatus epilepticus (SE) is a serious health issue in developing countries, with high morbidity and mortality rates of 3%–46%. There are two types of SE, convulsive status epilepticus (CSE) and non-convulsive status epilepticus. The most common type, CSE, is easy to detect but, in several cases, the patients are diagnosed too late to be properly treated and hospitalized. The present study therefore investigated the clinical manifestations of C...
Source: Epilepsy and Behavior Case Reports - March 16, 2019 Category: Neurology Source Type: research

Psychometric properties of the care dependency scale in stroke survivors in Indonesian hospitals
Publication date: Available online 8 July 2020Source: International Journal of Nursing SciencesAuthor(s): Nursiswati Nursiswati, Ruud JG. Halfens, Christa Lohrmann
Source: International Journal of Nursing Sciences - July 9, 2020 Category: Nursing Source Type: research

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Early detection and warning in interventional radiology (edwin) system improves patient safety and radiation dose optimization at professor ngoerah public hospital, bali, indonesia
The Indonesian Ministry of Health conducted a health transformation with plans to develop hospitals for services related to heart disease, stroke, cancer, and urology, the four diseases that cause the highest mortality rate in Indonesia. This mission requires Interventional Radiology Modalities involving the use of ionizing radiation. Therefore, the EDWIN system is crucial for improving patient safety and radiation dose optimization, to detect and alert potential radiation dose and use of contrast media (CM) in real-time, allowing for timely adjustments to be made to optimize radiation exposure and CM use to the patient.
Source: Journal of Medical Imaging and Radiation Sciences - August 23, 2023 Category: Radiology Authors: I Putu Adi Susanta, I Dewa Putu Wira Armawa, Putu Irma Wulandari, Sugiyanto Source Type: research

Pages: 1  2